Compare PODC & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PODC | INKT |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.5M | 57.6M |
| IPO Year | 2022 | 2021 |
| Metric | PODC | INKT |
|---|---|---|
| Price | $2.38 | $10.53 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 148.9K | 4.6K |
| Earning Date | 05-04-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $21.33 | N/A |
| Revenue Next Year | $19.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.30 | $6.66 |
| 52 Week High | $3.35 | $76.00 |
| Indicator | PODC | INKT |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 35.24 |
| Support Level | $1.89 | $6.85 |
| Resistance Level | $2.41 | $12.78 |
| Average True Range (ATR) | 0.19 | 0.36 |
| MACD | -0.05 | -0.04 |
| Stochastic Oscillator | 6.85 | 11.27 |
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.